MarketCap
Cyclerion Therapeutics CYCN
$ 34.99
3.77%
Facebook
X
Telegram
Cyclerion Therapeutics PEG Ratio | CYCN
Annual PEG Ratio Cyclerion Therapeutics
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.0574 | -0.0367 | -0.0345 | - | - | - | -0.0283 | 0.119 | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.119 | -0.0574 | -0.00763 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Innoviva
INVA
|
0.012 | $ 19.09 | -0.78 % | $ 1.29 B |  USA |
 |
BioCardia
BCDA
|
-0.00515 | $ 0.86 | -3.12 % | $ 5.73 M | USA |
 |
Kindred Biosciences, Inc.
KIN
|
0.138 | - | 0.11 % | $ 419 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-0.0509 | $ 2.44 | 9.91 % | $ 15.6 B |  Australia |
 |
Shineco, Inc.
TYHT
|
0.00247 | - | -3.90 % | $ 97.2 M |  China |
 |
Millendo Therapeutics, Inc.
MLND
|
-0.00169 | - | -5.36 % | $ 20.2 M | USA |
 |
Certara
CERT
|
-13 | $ 12.12 | -0.53 % | $ 1.94 B | USA |
 |
Dyadic International
DYAI
|
0.649 | $ 0.33 | -2.68 % | $ 11.9 M | USA |
 |
Intec Pharma Ltd
NTEC
|
-0.0162 | - | -12.45 % | $ 17.7 M |  Israel |
 |
Oramed Pharmaceuticals
ORMP
|
0.458 | $ 3.86 | -0.77 % | $ 160 M | Israel |
 |
Anika Therapeutics
ANIK
|
0.147 | $ 14.56 | -24.68 % | $ 209 M | USA |
 |
Aprea Therapeutics
APRE
|
0.000017 | $ 0.53 | 6.6 % | $ 3.47 M | USA |
 |
Galectin Therapeutics
GALT
|
-14.3 | $ 3.13 | 4.86 % | $ 200 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
-4.04 | $ 72.79 | 1.62 % | $ 7.56 B | USA |
 |
Progenity, Inc.
PROG
|
0.0586 | - | -3.47 % | $ 164 M | USA |
 |
Genprex
GNPX
|
-0.000095 | $ 2.09 | -0.48 % | $ 1.95 M | USA |
 |
Strongbridge Biopharma plc
SBBP
|
-0.235 | - | 1.52 % | $ 136 M | USA |
 |
Innate Pharma S.A.
IPHA
|
0.00448 | $ 1.43 | 2.14 % | $ 128 M |  France |
 |
Seneca Biopharma, Inc.
SNCA
|
0.000349 | - | -1.19 % | $ 28.7 M | USA |
 |
BioMarin Pharmaceutical
BMRN
|
0.177 | $ 56.03 | -0.16 % | $ 10.7 B | USA |
 |
Matinas BioPharma Holdings
MTNB
|
-0.000281 | $ 1.15 | -0.86 % | $ 6.3 M | USA |
 |
Enanta Pharmaceuticals
ENTA
|
-0.000104 | $ 10.99 | 9.03 % | $ 234 K | USA |
 |
Milestone Pharmaceuticals
MIST
|
102 | $ 0.76 | 9.73 % | $ 80.7 M |  Canada |
 |
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
-0.47 | $ 93.79 | 6.17 % | $ 6.96 B | USA |
 |
Lipocine
LPCN
|
0.00177 | $ 1.58 | 3.27 % | $ 8.61 M | USA |
 |
Seres Therapeutics
MCRB
|
0.0307 | $ 1.97 | -5.74 % | $ 17.5 M | USA |
 |
Madrigal Pharmaceuticals
MDGL
|
-9.96 | $ 399.41 | -0.17 % | $ 8.96 B | USA |
 |
CEL-SCI Corporation
CVM
|
-0.00238 | $ 1.44 | 6.67 % | $ 11.5 M | USA |
 |
Inventiva S.A.
IVA
|
-0.75 | $ 3.8 | 4.68 % | $ 227 M | France |
 |
MeiraGTx Holdings plc
MGTX
|
-128 | $ 9.0 | 5.73 % | $ 724 M | USA |
 |
Processa Pharmaceuticals
PCSA
|
-0.000309 | $ 1.93 | 4.89 % | $ 2.53 M | USA |
 |
Eton Pharmaceuticals
ETON
|
-1.07 | $ 56.44 | 19.7 % | $ 1.52 B | USA |
 |
IDEAYA Biosciences
IDYA
|
-1.47 | $ 31.24 | 1.92 % | $ 2.76 B | USA |
 |
Lantern Pharma
LTRN
|
-0.06 | $ 0.56 | 4.61 % | $ 6.1 M | USA |
 |
Foghorn Therapeutics
FHTX
|
0.207 | $ 1.86 | -2.62 % | $ 117 M | USA |
 |
Ocugen
OCGN
|
-1.34 | $ 0.93 | 13.53 % | $ 291 M | USA |
 |
Oncolytics Biotech
ONCY
|
0.201 | $ 0.44 | -2.01 % | $ 42.2 M | Canada |
 |
Minerva Neurosciences
NERV
|
0.000059 | $ 2.42 | 5.0 % | $ 20.5 M | USA |
 |
Kamada Ltd.
KMDA
|
-0.244 | $ 7.22 | 5.09 % | $ 416 M | Israel |
 |
Neurocrine Biosciences
NBIX
|
0.957 | $ 164.42 | 2.91 % | $ 16.4 B | USA |
 |
Nanobiotix S.A.
NBTX
|
0.249 | $ 30.7 | 2.05 % | $ 1.47 T | France |
 |
Mereo BioPharma Group plc
MREO
|
-0.000588 | $ 0.28 | 0.93 % | $ 223 M |  Britain |
 |
Maravai LifeSciences Holdings
MRVI
|
-0.0142 | $ 7.53 | 7.81 % | $ 1.09 B | USA |
 |
Lexicon Pharmaceuticals
LXRX
|
0.105 | $ 1.78 | 10.25 % | $ 646 M | USA |
 |
Moleculin Biotech
MBRX
|
-0.00013 | $ 8.87 | 1.6 % | $ 10.5 M | USA |
 |
Nurix Therapeutics
NRIX
|
-0.478 | $ 15.3 | 3.1 % | $ 1.33 B | USA |
 |
Nkarta
NKTX
|
0.126 | $ 1.75 | 11.15 % | $ 129 M | USA |
 |
MacroGenics
MGNX
|
311 | $ 2.35 | 5.86 % | $ 148 M | USA |
 |
Protagonist Therapeutics
PTGX
|
0.419 | $ 131.96 | -2.54 % | $ 8.39 B | USA |